Int J Stomatol ›› 2020, Vol. 47 ›› Issue (1): 95-101.doi: 10.7518/gjkq.2020009
• Reviews • Previous Articles Next Articles
Zeng Kan,Li Xin,Wang Chenglin,Yang Jing,Ye Ling()
CLC Number:
[1] | Cetin K, Christiansen CF, Sværke C , et al. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the pro-gnostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval[J]. BMJ Open, 2015,5(4):e007702. |
[2] | Uhr JW, Pantel K . Controversies in clinical cancer dormancy[J]. Proc Natl Acad Sci USA, 2011,108(30):12396-12400. |
[3] | 孟琳, 王丹丹, 唐琪 , 等. 肿瘤休眠及其相关机制研究进展[J]. 吉林大学学报(医学版), 2016,42(5):1030-1033. |
Meng L, Wang DD, Tang Q , et al. Advanced research on tumor dormancy and its correlative mechanism[J]. J Jilin Univ (Med Ed), 2016,42(5):1030-1033. | |
[4] | Croucher PI ,McDonald MM,Martin TJ. Bone metastasis: the importance of the neighbourhood[J]. Nat Rev Cancer, 2016,16(6):373-386. |
[5] | Quayle L, Ottewell PD, Holen I . Bone metastasis: molecular mechanisms implicated in tumour cell dormancy in breast and prostate cancer[J]. Curr Cancer Drug Targets, 2015,15(6):469-480. |
[6] | Monteiro AC, Leal AC, Gonçalves-Silva T , et al. T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse mo-del of metastatic breast cancer[J]. PLoS One, 2013,8(7):e68171. |
[7] | Ghajar CM, Peinado H, Mori H , et al. The perivas-cular Niche regulates breast tumour dormancy[J]. Nat Cell Biol, 2013,15(7):807-817. |
[8] | Sosa MS, Bragado P, Aguirre-Ghiso JA . Mechanisms of disseminated cancer cell dormancy: an awakening field[J]. Nat Rev Cancer, 2014,14(9):611-622. |
[9] | Aguirre Ghiso JA . Inhibition of FAK signaling ac-tivated by urokinase receptor induces dormancy in human carcinoma cells in vivo[J]. Oncogene, 2002,21(16):2513-2524. |
[10] | Aguirre Ghiso JA, Kovalski K, Ossowski L . Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling[J]. J Cell Biol, 1999,147(1):89-104. |
[11] | Liu D, Aguirre Ghiso J, Estrada Y , et al. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human car-cinoma[J]. Cancer Cell, 2002,1(5):445-457. |
[12] | Aguirre-Ghiso JA, Ossowski L, Rosenbaum SK . Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during pri-mary and metastatic growth[J]. Cancer Res, 2004,64(20):7336-7345. |
[13] | Bartkowiak K, Effenberger KE, Harder S , et al. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients[J]. J Proteome Res, 2010,9(6):3158-3168. |
[14] | Hosokawa N, Hara T, Kaizuka T , et al. Nutrient-dependent MTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy[J]. Mol Biol Cell, 2009,20(7):1981-1991. |
[15] | 张玉梅, 冯凡, 林方方 , 等. 自噬相关基因ATG5在肿瘤发生发展及治疗中的作用[J]. 中国肿瘤, 2018,27(10):774-778. |
Zhang YM, Feng F, Lin FF , et al. Roles of auto-phagy-related gene 5 (ATG5) in tumor development, treatment and prognosis[J]. China Cancer, 2018,27(10):774-778. | |
[16] | Malladi S, Macalinao DG, Jin X , et al. Metastatic latency and immune evasion through autocrine inhibition of WNT[J]. Cell, 2016,165(1):45-60. |
[17] | Zhuang XQ, Zhang H, Li XY , et al. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1[J]. Nat Cell Biol, 2017,19(10):1274-1285. |
[18] | Wang H, Yu CJ, Gao X , et al. The osteogenic Niche promotes early-stage bone colonization of disse-minated breast cancer cells[J]. Cancer Cell, 2015,27(2):193-210. |
[19] | Ren GW, Esposito M, Kang YB . Bone metastasis and the metastatic Niche[J]. J Mol Med, 2015,93(11):1203-1212. |
[20] | Buenrostro D, Park SI, Sterling JA . Dissecting the role of bone marrow stromal cells on bone metas-tases[J]. Biomed Res Int, 2014,2014:875305. |
[21] | Sun YN, Mao XY, Fan CF , et al. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis[J]. Tumor Biol, 2014,35(8):7765-7773. |
[22] | Luker KE, Lewin SA, Mihalko LA , et al. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells[J]. Oncogene, 2012,31(45):4750-4758. |
[23] | Boudot A, Kerdivel G, Habauzit D , et al. Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells[J]. PLoS One, 2011,6(6):e20898. |
[24] | Wang N, Docherty FE, Brown HK , et al. Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models[J]. J Bone Miner Res, 2014,29(12):2688-2696. |
[25] | Grudowska A, Czaplińska D, Polom W , et al. Tetras-panin CD151 mediates communication between PC3 prostate cancer cells and osteoblasts[J]. Acta Biochim Pol, 2017,64(1):135-141. |
[26] | Wang H, Tian L, Liu J , et al.The osteogenic Niche is a calcium reservoir of bone micrometastases and confers unexpected therapeutic vulnerability[J].Cancer Cell, 2018, 34(5):823- 839.e7. |
[27] | Weilbaecher KN, Guise TA , McCauley LK. Cancer to bone: a fatal attraction[J]. Nat Rev Cancer, 2011,11(6):411-425. |
[28] | Hirshberg A, Berger R, Allon I , et al. Metastatic tumors to the jaws and mouth[J]. Head Neck Pathol, 2014,8(4):463-474. |
[29] | Zheng Y, Chow SO, Boernert K , et al. Direct cross-talk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways[J]. J Bone Miner Res, 2014,29(9):1938-1949. |
[30] | Luo XM, Fu YJ, Loza AJ , et al. Stromal-initiated changes in the bone promote metastatic niche deve-lopment[J]. Cell Rep, 2016,14(1):82-92. |
[31] | Esposito M, Guise T, Kang YB . The biology of bone metastasis[J]. Cold Spring Harb Perspect Med, 2018,8(6):a031252. |
[32] | Yin JJ, Selander K, Chirgwin JM , et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development[J]. J Clin Invest, 1999,103(2):197-206. |
[33] | Lu X, Mu E, Wei Y , et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast pro-genitors[J]. Cancer Cell, 2011,20(6):701-714. |
[34] | Sethi N, Dai XD, Winter CG , et al. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells[J]. Cancer Cell, 2011,19(2):192-205. |
[35] | Lynch CC, Hikosaka A, Acuff HB , et al. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL[J]. Cancer Cell, 2005,7(5):485-496. |
[36] | Lu X, Wang QQ, Hu GH , et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis[J]. Genes Dev, 2009,23(16):1882-1894. |
[37] | Kelly T, Suva LJ, Huang Y , et al. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metas-tases[J]. Cancer Res, 2005,65(13):5778-5784. |
[38] | Cher ML, Biliran HR Jr, Bhagat S , et al. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis[J]. Proc Natl Acad Sci U S A, 2003,100(13):7847-7852. |
[39] | Dormady SP, Zhang XM, Basch RS . Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene-6 (GAS6)[J]. Proc Natl Acad Sci U S A, 2000,97(22):12260-12265. |
[40] | Jung Y, Shiozawa Y, Wang JC , et al. Prevalence of prostate cancer metastases after intravenous inocula-tion provides clues into the molecular basis of dor-mancy in the bone marrow microenvironment[J]. Neoplasia, 2012,14(5):429-439. |
[41] | Shiozawa Y, Pedersen EA, Patel LR , et al. GAS6/AXL Axis regulates prostate cancer invasion, proli-feration, and survival in the bone marrow niche[J]. Neoplasia, 2010,12(2):116-127. |
[42] | Kobayashi A, Okuda H, Xing F , et al. Bone morpho-genetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone[J]. J Exp Med, 2011,208(13):2641-2655. |
[43] | Kim JK, Jung Y, Wang JC , et al. TBK1 regulates prostate cancer dormancy through mTOR inhibition[J]. Neoplasia, 2013,15(9):1064-1074. |
[44] | Feuerer M, Rocha M, Bai L , et al. Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients[J]. Int J Cancer, 2001,92(1):96-105. |
[45] | Sawant A, Hensel JA, Chanda D , et al. Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells[J]. J Immunol, 2012,189(9):4258-4265. |
[46] | Wu AC, He YW, Broomfield A , et al. CD169+ ma-crophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer[J]. J Pathol, 2016,239(2):218-230. |
[47] | Kianercy A, Pienta KJ . Positive feedback loops be-tween inflammatory, bone and cancer cells during metastatic niche construction[J]. Adv Exp Med Biol, 2016,936:137-148. |
[48] | Mulcrone PL, Campbell JP, Clément-Demange L , et al. Skeletal colonization by breast cancer cells is stimulated by an osteoblast and β2AR-dependent neo-angiogenic switch[J]. J Bone Miner Res, 2017,32(7):1442-1454. |